CN110101825A - 一种治疗癌症的中药 - Google Patents
一种治疗癌症的中药 Download PDFInfo
- Publication number
- CN110101825A CN110101825A CN201910552178.XA CN201910552178A CN110101825A CN 110101825 A CN110101825 A CN 110101825A CN 201910552178 A CN201910552178 A CN 201910552178A CN 110101825 A CN110101825 A CN 110101825A
- Authority
- CN
- China
- Prior art keywords
- radix
- cancer
- treatment
- chinese medicine
- chaulmoogra
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 43
- 206010028980 Neoplasm Diseases 0.000 title claims abstract description 39
- 201000011510 cancer Diseases 0.000 title claims abstract description 34
- 235000007516 Chrysanthemum Nutrition 0.000 claims abstract description 18
- 241000246500 Gentianella aspera Species 0.000 claims abstract description 18
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 18
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 18
- 244000197580 Poria cocos Species 0.000 claims abstract description 18
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 18
- 240000004980 Rheum officinale Species 0.000 claims abstract description 18
- 235000008081 Rheum officinale Nutrition 0.000 claims abstract description 18
- 210000000582 semen Anatomy 0.000 claims abstract description 18
- 241000558306 Gynocardia odorata Species 0.000 claims abstract description 17
- 241000283966 Pholidota <mammal> Species 0.000 claims abstract description 17
- 241000756943 Codonopsis Species 0.000 claims abstract description 15
- 239000002994 raw material Substances 0.000 claims abstract description 4
- 239000000203 mixture Substances 0.000 claims description 24
- 241000723353 Chrysanthemum Species 0.000 claims description 17
- 235000013305 food Nutrition 0.000 claims description 6
- 230000001965 increasing effect Effects 0.000 claims description 6
- 239000000463 material Substances 0.000 claims description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 5
- 238000001816 cooling Methods 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- 239000000843 powder Substances 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 5
- 238000010298 pulverizing process Methods 0.000 claims description 5
- 230000000694 effects Effects 0.000 abstract description 21
- 230000036407 pain Effects 0.000 abstract description 11
- 206010061902 Pancreatic neoplasm Diseases 0.000 abstract description 5
- 208000005718 Stomach Neoplasms Diseases 0.000 abstract description 5
- 206010017758 gastric cancer Diseases 0.000 abstract description 5
- 230000036039 immunity Effects 0.000 abstract description 5
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 abstract description 5
- 201000011549 stomach cancer Diseases 0.000 abstract description 5
- 208000005016 Intestinal Neoplasms Diseases 0.000 abstract description 4
- 201000002313 intestinal cancer Diseases 0.000 abstract description 4
- 206010058467 Lung neoplasm malignant Diseases 0.000 abstract description 3
- 230000000202 analgesic effect Effects 0.000 abstract description 3
- 201000007270 liver cancer Diseases 0.000 abstract description 3
- 208000014018 liver neoplasm Diseases 0.000 abstract description 3
- 201000005202 lung cancer Diseases 0.000 abstract description 3
- 208000020816 lung neoplasm Diseases 0.000 abstract description 3
- 230000001225 therapeutic effect Effects 0.000 abstract description 3
- 230000009286 beneficial effect Effects 0.000 abstract description 2
- 229940126678 chinese medicines Drugs 0.000 abstract description 2
- 230000002265 prevention Effects 0.000 abstract description 2
- 244000189548 Chrysanthemum x morifolium Species 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 description 10
- 239000008280 blood Substances 0.000 description 10
- 238000002512 chemotherapy Methods 0.000 description 8
- 210000004185 liver Anatomy 0.000 description 7
- 208000004880 Polyuria Diseases 0.000 description 5
- 230000035619 diuresis Effects 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 241001251949 Xanthium sibiricum Species 0.000 description 4
- 230000003110 anti-inflammatory effect Effects 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 238000002651 drug therapy Methods 0.000 description 4
- 230000000259 anti-tumor effect Effects 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000003907 kidney function Effects 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 2
- 206010073069 Hepatic cancer Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 230000013872 defecation Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 206010073071 hepatocellular carcinoma Diseases 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 230000003908 liver function Effects 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 230000002980 postoperative effect Effects 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 210000004881 tumor cell Anatomy 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 208000028399 Critical Illness Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 241001179022 Hydnocarpus anthelminthicus Species 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 208000007433 Lymphatic Metastasis Diseases 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 201000011603 cardia cancer Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- BFPSDSIWYFKGBC-UHFFFAOYSA-N chlorotrianisene Chemical compound C1=CC(OC)=CC=C1C(Cl)=C(C=1C=CC(OC)=CC=1)C1=CC=C(OC)C=C1 BFPSDSIWYFKGBC-UHFFFAOYSA-N 0.000 description 1
- 201000001883 cholelithiasis Diseases 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 208000008384 ileus Diseases 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 201000007294 immune system cancer Diseases 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 235000021590 normal diet Nutrition 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 210000001187 pylorus Anatomy 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/344—Codonopsis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/51—Gentianaceae (Gentian family)
- A61K36/515—Gentiana
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/59—Menispermaceae (Moonseed family), e.g. hyperbaena or coralbead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Cell Biology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Zoology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种治疗癌症的中药,由以下原料制成:茯苓,党参,白术,黄花,当归,半枝莲,甘草,穿山甲,大黄,三七,防己,郁金,大风子,木鳖子,龙胆。本发明一种治疗癌症的中药的有益效果是费用成本低,治疗费用低治疗效果好,对治疗肝癌、胃癌、肠癌、肺癌和胰腺癌具有显著止痛效果,通过患者免疫力的提升,癌症患者在手术、放化疗以后服用本药起到了预防复发的作用。对晚期癌症患者服用本药后能减少痛苦,延长生命。早期的癌症患者服用本药,也具有较好的疗效。
Description
技术领域
本发明涉及中药制药领域,尤其涉及一种治疗癌症的中药。
背景技术
肿瘤是当今世界医学攻关的一大难题,严重威胁着人类的建康和生命安全。目前医学界治疗各种肿瘤、癌症包块以切除、化疗为主,配合服药,治愈病例极少,同时还产生负作用。癌症成为难治之症。有些癌症能够手术治疗, 而对于不能手术治疗的癌症患者只能采用药物治疗,以延长患者的生命。目前用于治疗这类疾病的药物多为化学合成药,而化学合成药不但费用高昂,而且对身体伤害非常大,给病者带来极大的痛苦,远期疗效不佳,不易长期服用,特别是对于一些肠胃病患者或肝肾功能不全者要求慎用,且化疗虽然是全身性治疗,但只能消灭一定比例的肿瘤细胞,残留的部分细胞很快又会长出来,而且化疗剂在杀灭肿瘤细胞的同时,也会杀伤大量正常细胞,使脏腑等重要器官功能严重受损,同时又抑制或破坏免疫系统癌症能够引发各种疼痛,这就加剧了患者的痛苦,特别是癌症晚期,对于这类患者只能采用一些止疼的药物缓解症状,以减轻患者疼痛的程度。基于此,大力发展中医中药的手段来治疗肿瘤疾病是亟待开发的新途径。发明一种能够从根本上行 治疗癌症的中药,治疗成本低,适用范围广,以提高病者生存、生活质量,防止癌症复发和转移。
发明内容
发明目的:本发明所要解决癌症治疗采用化学药物存在的费用高昂,人体伤害大,疗效不佳,病者生活质量差的技术问题,本发明提供一种治疗癌症的中药。
技术方案:本发明提供一种治疗癌症的中药,包括:按重量份计,由以下原料制成:茯苓8-15g,党参8-15g,白术8-15g,黄花8-15g,当归8-15g,半枝莲8-15g,甘草8-15g,穿山甲8-10g,大黄5-10g,三七5-10g,防己4-8g,郁金3-7g,大风子0.1-0.3g,木鳖子0.2-0.5g,龙胆1-3g。
优选的,包括以重量计的茯苓8g,党参8g,白术9g,黄花8g,当归9g,半枝莲8g,甘草10g,穿山甲8g,大黄6g,三七6g,防己7g,郁金4g,大风子0.1g,木鳖子0.2g,龙胆1g。
优选的,包括以重量计的茯苓10g,党参9g,白术10g,黄花10g,当归10g,半枝莲10g,甘草9g,穿山甲9g,大黄8g,三七7g,防己8g,郁金5g,大风子0.2g,木鳖子0.3g,龙胆2g。
优选的,包括以重量计的茯苓12g,党参11g,白术12g,黄花10g,当归12g,半枝莲11g,甘草10g,穿山甲10g,大黄8g,三七8g,防己7g,郁金6g,大风子0.3g,木鳖子0.4g,龙胆3g。
本发明所选用原料药理功效如下:
茯苓:败毒抗瘤、痰饮咳逆、利水消肿、健脾止泻、养心安神、增强免疫力的功效。
党参:补中益气、和胃生津、祛痰止咳、降血压、健脾益肺的功效。
白术:降血糖、利尿、抗菌、促进造血、抗瘤、提升因化疗下降的白血球的功效。
黄花:健胃、消肿、养血平肝、镇痛、治疗肝炎、清利湿热、养心德功效。
当归:补血养血、润肠通便、抗癌、增强免疫力的功效。
半枝莲:利尿消肿、散瘀化痰、止痛、治癌、治疗肝硬化、免疫调节的功效。
甘草:抗炎、抗过敏、治疗脾胃气虚、所含次酸阻断致癌物诱发肿瘤生长的功效。
穿山甲:活血散瘀、通行经络、消肿排脓、调理血气、术后抗炎的功效。
大黄:解毒消痈、泻下攻积、泻火解毒、活血祛瘀、利湿退黄的功效。
三七:散瘀止血、消肿定痛、补血止血、抗血栓、增强免疫力的功效。
防己:祛风止痛、清热利水的功效。
郁金:行气解郁、凉血破瘀、治热、治神昏的功效。
大风子:祛风燥湿、攻毒杀虫、降血脂、抗炎、抗肿瘤的功效。
木鳖子:散结消肿、攻毒疗疮、祛毒、治痔疮的功效。
龙胆:保肝、镇静、抗菌消炎、调节免疫系统的功效。
本发明还提供了一种治疗癌症的中药的制备方法,包括以下步骤:
(1)挑取优良的各种食品药材洗净,切片;
(2)取黄花、半枝莲、甘草、大黄、三七、大风子和木鳖子混合均匀,煎煮过滤,冷却浓缩成浸膏,烘干粉碎成粉末,得到混合物A;
(3)取茯苓、党参、白术、当归、穿山甲、防己、郁金和龙胆混合,加高度酒精浸泡,经过滤、浓缩得到浸膏,再经过干燥后粉碎,得到混合物B;
(4)将混合物A和混合物B混合均匀;
(5)杀菌、消毒,装瓶成药剂。
本发明一种治疗癌症的中药的有益效果是费用成本低,治疗费用低治疗效果好,对治疗肝癌、胃癌、肠癌、肺癌和胰腺癌具有显著止痛效果,并且具有补益脏腑、镇静安神、消肿止痛、行气通络、逐步缩小肿块,达到减轻患者痛苦,提高生存质量,延长寿命的作用,另外通过患者免疫力的提升,癌症患者在手术、放化疗以后服用本药起到了预防复发的作用。对晚期癌症患者服用本药后能减少痛苦,延长生命。早期的癌症患者服用 本药,也具有较好的疗效。
具体实施方式
以下通过具体实施例对本发明做进一步阐述,应当指出:对于本工艺领域的普通工艺人员来说,在不脱离本发明原理的前提下,对本发明的各种等价形式的修改均落于本申请所附权利要求所限定的范围。
实施例1
一种治疗癌症的中药,包括以重量计的茯苓8g,党参8g,白术9g,黄花8g,当归9g,半枝莲8g,甘草10g,穿山甲8g,大黄6g,三七6g,防己7g,郁金4g,大风子0.1g,木鳖子0.2g,龙胆1g。
本实施例的制备方法,包括以下步骤:
(1)挑取优良的各种食品药材洗净,切片;
(2)取黄花、半枝莲、甘草、大黄、三七、大风子和木鳖子混合均匀,煎煮过滤,冷却浓缩成浸膏,烘干粉碎成粉末,得到混合物A;
(3)取茯苓、党参、白术、当归、穿山甲、防己、郁金和龙胆混合,加高度酒精浸泡,经过滤、浓缩得到浸膏,再经过干燥后粉碎,得到混合物B;
(4)将混合物A和混合物B混合均匀;
(5)杀菌、消毒,装瓶成药剂。
实施例2
一种治疗癌症的中药,包括以重量计的茯苓10g,党参9g,白术10g,黄花10g,当归10g,半枝莲10g,甘草9g,穿山甲9g,大黄8g,三七7g,防己8g,郁金5g,大风子0.2g,木鳖子0.3g,龙胆2g。
本实施例的制备方法,包括以下步骤:
(1)挑取优良的各种食品药材洗净,切片;
(2)取黄花、半枝莲、甘草、大黄、三七、大风子和木鳖子混合均匀,煎煮过滤,冷却浓缩成浸膏,烘干粉碎成粉末,得到混合物A;
(3)取茯苓、党参、白术、当归、穿山甲、防己、郁金和龙胆混合,加高度酒精浸泡,经过滤、浓缩得到浸膏,再经过干燥后粉碎,得到混合物B;
(4)将混合物A和混合物B混合均匀;
(5)杀菌、消毒,装瓶成药剂。
实施例3
一种治疗癌症的中药,包括以重量计的茯苓12g,党参11g,白术12g,黄花10g,当归12g,半枝莲11g,甘草10g,穿山甲10g,大黄8g,三七8g,防己7g,郁金6g,大风子0.3g,木鳖子0.4g,龙胆3g。
本实施例的制备方法,包括以下步骤:
(1)挑取优良的各种食品药材洗净,切片;
(2)取黄花、半枝莲、甘草、大黄、三七、大风子和木鳖子混合均匀,煎煮过滤,冷却浓缩成浸膏,烘干粉碎成粉末,得到混合物A;
(3)取茯苓、党参、白术、当归、穿山甲、防己、郁金和龙胆混合,加高度酒精浸泡,经过滤、浓缩得到浸膏,再经过干燥后粉碎,得到混合物B;
(4)将混合物A和混合物B混合均匀;
(5)杀菌、消毒,装瓶成药剂。
临床应用
(1)治疗方法及服用方式
采用由本发明中药治疗,一日三次,饭前半小时服用,每次3g,一个月为一个疗程。治疗期间停用其它药物。患者治疗前后按统一要求做有关检查并详细记录。
(2)疗效标准
治愈:经用本发明药物治疗后疼痛消失,肿块消除,正常饮食,体重上升,可参加体力劳动;
有效:经用本发明药物治疗后疼痛减轻,肿块消除达一半以上,饮食情况改善;
无效:经用本发明药物治疗后较治疗前无改善。
(3)典型病例
样本量近600例的严格临床试验显示:尤其是胃癌、肝癌的临床治疗中具有显著的疗效,总缓解率高于国家标准3.3倍,高于临床同比化疗组11倍,总有效率高达9312%,超过同比化疗组总有效率71.48%近22个百分点。在近1000例针对肠癌、胰腺癌、肺癌、等其他癌症开展的临床治疗中,也取得了良好的疗效,以下为部分典型病例。
孙某,男,60岁。患者因进食受阻伴上腹部隐痛不适2月在市二院作Gl检查示胃底贲门癌,于1999年1 1月4号作纤维胃镜检查活检,病理报告胃贲门腺癌Il级。於1999年1 1月23日入院,1969年因胆石症行胆囊切除,1983年、1988年2次行粘连性肠梗阻松解术。按本发明中药,口服2次,每次15ml,用后分别于99年1 1月25日一29日及99年1 2月27日一31日用MF方案(MMClo mg,D1、5一Fu750mgDl—5)化疗二周期,二次化疗后血常规均正常,复查肝肾功能亦正常,第二周期化疗后复查Gl,病灶显示不明显,仅见小弯处粘膜中断。二周期后坚持服用百草苓合剂1年(1 5ml Bid)随访至2001年1 0月23日,能进普食,生活自理,Gl示胃底软组织影,肝、腹腔淋巴结,肺均未发现转移灶。
朱某,男,59岁,原发性肝癌,1999年9月10日入院,临床诊断为原发性肝癌,II期瘀毒积滞证,按方案给本发明中药,每日二次,每次1 5ml,分别于服用后1、5周行TACE术经肝动脉导管灌注DDP90mg,ADM50mg,5一Ful 000mg,术后略有发热,肝区痛。在百草苓合剂连续服药二个月过程中,未见明显不良反应,二个月后复查,临床症状改善,卡氏积分由治疗前80升至治疗后的90,治疗前的发热、乏力等症状经治明显减轻;舌质暗红,舌苔薄白,脉弦,肝肋下4cm,脾肋下未及,腹水(一),实验室检查:ALT正常,AKP正常,AFP<30ug/L,肿瘤大小由8.6cmX9cm缩小至8cm×6.2cm;治疗中血象、肝肾功能等无明显变化,目前患者生活自理,能进行正常活动。
吴某,女,年60岁,低分化胃癌,1995年因胃部不适,查有幽门低分化胃癌,即行手术切除胃部2/3,此时,癌细胞已有淋巴结转移。全身情况极差,浑身无力,食欲全无,便秘,体重急剧下降到69斤。后托人寻找,开始服用本发明中药,一天4次,每次10毫升,服药二天以后,,有饥饿感,大便也通畅了,体重也逐渐从69斤增加到86斤,此后一直坚持服了8年。剂量也逐渐减少,由起初是每天40毫升,连续服用了三年多时间后,改为每天服1 6毫升维持量。之后的数次胃镜检查均未见有任何癌细胞产生,也从未产生过复发转移的现象,健康状况一直很好。至今已生存1 0年。
陈某,男,56岁,胰腺癌晚期,2005年诊断为胰腺癌晚期,瘤体为10×8×6cm,伴有肝、胃、脊柱、肛门等广泛、性转移,因肿瘤无法切除而关腹。此后,病情急剧恶化,滴水不进,血色素下降至3克,医院下了病危通知。病危时刻,获悉百草苓合剂,即刻寻觅并开始服用百草苓合剂,几天后,奇迹出现,患者不仅能进食、排便、重新坐立,仅半月余,原来是病房中最危重的病人已成为全病区恢复最快、最好的病人。
庞某,女,现年61岁,肠癌,因广泛转移而不能手术,食欲差,大便无,体重急剧下降至76斤,此时,多方打听,服用本发明中药,治疗三个疗程,期间生活质量逐步提高,体质明显增加,从瘫痪在床到生活自理,半年后已如同正常人,97年随访,体重已增至130斤,病迹全无。至今已生存18年。
Claims (5)
1.一种治疗癌症的中药,其特征在于,按重量份计,由以下原料制成:茯苓8-15g,党参8-15g,白术8-15g,黄花8-15g,当归8-15g,半枝莲8-15g,甘草8-15g,穿山甲8-10g,大黄5-10g,三七5-10g,防己4-8g,郁金3-7g,大风子0.1-0.3g,木鳖子0.2-0.5g,龙胆1-3g。
2.根据权利要求1所述一种治疗癌症的中药,其特征在于,包括以重量计的茯苓8g,党参8g,白术9g,黄花8g,当归9g,半枝莲8g,甘草10g,穿山甲8g,大黄6g,三七6g,防己7g,郁金4g,大风子0.1g,木鳖子0.2g,龙胆1g。
3.根据权利要求1所述一种治疗癌症的中药,其特征在于,包括以重量计的茯苓10g,党参9g,白术10g,黄花10g,当归10g,半枝莲10g,甘草9g,穿山甲9g,大黄8g,三七7g,防己8g,郁金5g,大风子0.2g,木鳖子0.3g,龙胆2g。
4.根据权利要求1所述一种治疗癌症的中药,其特征在于,包括以重量计的茯苓12g,党参11g,白术12g,黄花10g,当归12g,半枝莲11g,甘草10g,穿山甲10g,大黄8g,三七8g,防己7g,郁金6g,大风子0.3g,木鳖子0.4g,龙胆3g。
5.根据权利要求1所述一种治疗癌症的中药的制备方法,其特征在于,包括以下步骤:
(1)挑取优良的各种食品药材洗净,切片;
(2)取黄花、半枝莲、甘草、大黄、三七、大风子和木鳖子混合均匀,煎煮过滤,冷却浓缩成浸膏,烘干粉碎成粉末,得到混合物A;
(3)取茯苓、党参、白术、当归、穿山甲、防己、郁金和龙胆混合,加高度酒精浸泡,经过滤、浓缩得到浸膏,再经过干燥后粉碎,得到混合物B;
(4)将混合物A和混合物B混合均匀;
(5)杀菌、消毒,装瓶成药剂。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910552178.XA CN110101825A (zh) | 2019-06-25 | 2019-06-25 | 一种治疗癌症的中药 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910552178.XA CN110101825A (zh) | 2019-06-25 | 2019-06-25 | 一种治疗癌症的中药 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110101825A true CN110101825A (zh) | 2019-08-09 |
Family
ID=67495821
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910552178.XA Pending CN110101825A (zh) | 2019-06-25 | 2019-06-25 | 一种治疗癌症的中药 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110101825A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110812436A (zh) * | 2019-11-25 | 2020-02-21 | 田同学 | 一组用于治疗子宫肌瘤的中药组合物及制备方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1103797A (zh) * | 1994-07-21 | 1995-06-21 | 李文忠 | 一种抗癌合剂及其制造方法 |
CN1252300A (zh) * | 1999-10-10 | 2000-05-10 | 黄晓维 | 抗癌转移药的配制方法 |
CN1546090A (zh) * | 2003-12-10 | 2004-11-17 | �Ϻ��ٿ�ҩҵ����˾ | 一种抗肿瘤的中药制剂及其制备方法和应用 |
CN103520659A (zh) * | 2013-11-01 | 2014-01-22 | 汤曙光 | 一种治疗癌症的中药 |
CN104013709A (zh) * | 2014-06-25 | 2014-09-03 | 王在峰 | 一种内服抗癌扶正汤药液 |
-
2019
- 2019-06-25 CN CN201910552178.XA patent/CN110101825A/zh active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1103797A (zh) * | 1994-07-21 | 1995-06-21 | 李文忠 | 一种抗癌合剂及其制造方法 |
CN1252300A (zh) * | 1999-10-10 | 2000-05-10 | 黄晓维 | 抗癌转移药的配制方法 |
CN1546090A (zh) * | 2003-12-10 | 2004-11-17 | �Ϻ��ٿ�ҩҵ����˾ | 一种抗肿瘤的中药制剂及其制备方法和应用 |
CN103520659A (zh) * | 2013-11-01 | 2014-01-22 | 汤曙光 | 一种治疗癌症的中药 |
CN104013709A (zh) * | 2014-06-25 | 2014-09-03 | 王在峰 | 一种内服抗癌扶正汤药液 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110812436A (zh) * | 2019-11-25 | 2020-02-21 | 田同学 | 一组用于治疗子宫肌瘤的中药组合物及制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103495040B (zh) | 治疗反流性食管炎的中药组合物及其颗粒剂制备方法 | |
CN103861079B (zh) | 一种清热止痛消瘤中药组合物 | |
CN106390013A (zh) | 一种抑制结直肠癌肝转移的复方中药组合物其制备方法与应用 | |
CN102716383B (zh) | 一种治疗克罗恩病的中药组合物 | |
CN101062146A (zh) | 一种治疗胃癌及骨癌的中药 | |
CN104548141B (zh) | 具有治疗胃肠溃疡功效且涂抹效果较好的消化道造影剂 | |
CN101708285A (zh) | 中药治疗癌症的组合及其制备方法 | |
CN110742990B (zh) | 一种治疗非酒精性单纯性脂肪肝的中药组合物及制剂和应用 | |
CN110101825A (zh) | 一种治疗癌症的中药 | |
WO2025015875A1 (zh) | 加味蜂房丸在制备治疗淋巴结炎药物中的应用 | |
CN104998140B (zh) | 一种用于慢性胃溃疡的中药制剂 | |
CN112274626A (zh) | 一种治疗癌症的中药组合物 | |
CN106619870A (zh) | 治疗消化系统肿瘤的组合物及其制备方法 | |
CN111840379A (zh) | 一种调理体质和防治各型乳房病证的智能系统贴膏及制法 | |
CN119424598B (zh) | 一种抗肺癌的中药组合物及其制备方法和应用 | |
CN117771334B (zh) | 调节自噬并抗乳腺肿瘤和结节的中药组合物及其制备方法和应用 | |
CN118320043B (zh) | 一种治疗非酒精性脂肪性肝炎的健脾通络降浊组合物 | |
CN103908495B (zh) | 提高肿瘤患者术后免疫功能的中药组合物及制法 | |
CN109010495A (zh) | 一种中药组合物及其制备方法和应用 | |
CN107243062A (zh) | 一种治疗胃痛的中药 | |
CN106581572A (zh) | 治疗乳癌的口服药物 | |
CN108721274B (zh) | 牛蒡子苷元在制备治疗慢性萎缩性胃炎药物中的用途 | |
CN106344755B (zh) | 一种用于治疗胃病的复方药物及其制备方法 | |
CN106214977A (zh) | 一种治疗噎膈的中药组合物 | |
CN105434533A (zh) | 一种治疗肝癌的中药组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190809 |